Home Business Ian Macleod appointed chair of Archangels
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Ian Macleod appointed chair of Archangels

by uma
30 views

 

Archangels, the world’s longest running business angel investment syndicate, based in Edinburgh, has appointed Ian Macleod as the new chair of its board.

The former investment analyst and fund manager takes over the helm from Eric Young, who has held the position since 2014. Eric will continue to sit on the Archangels board.

Ian Macleod worked in London and Paris for many years as an analyst, specialising in the electronics and telecoms industries, initially with ANZ Capel Cure Myers and longer spells at both NatWest Markets and Jeffries.

Later in his career, Ian focussed on smaller tech, cleantech and biotech companies, moving into fund management with 360 Asset Managers and more recently Accessible Clean Energy. Returning to Edinburgh in 2016, Ian joined the Archangels board in 2018.

Founded in 1992, Archangels is a leading business angel syndicate investing in early-stage Scottish life sciences and technology companies.

Archangels comprises around 120 members and a five strong full time executive team. In 2021, the syndicate invested £11.8m to reach a total of £23.6m including co-investment from Scottish Government agencies and other partners. There are currently 20 companies within the portfolio.

Ian Macleod, chair at Archangels, said: “The Scottish angel investment sector is helping to make Scotland a power house in the life science and technology industries. Archangels are at the forefront of that effort and it’s an honour to take on the role of chair”.

“While there may be challenging economic conditions ahead, by providing funding and a wealth of other support to our dynamic portfolio companies we can be optimistic about good outcomes for all our stakeholders”.

“Under Eric’s chairmanship, Archangels has gone from strength to strength over the last eight years and I’m glad to keep his senior counsel on the board. 

“I’m looking forward to supporting our portfolio businesses and investors, supporting entrepreneurialism and positively contributing to the Scottish economy.”

Eric Young, board member at Archangels, added: “With Ian’s long and highly successful career comes a great deal of experience and wisdom, all of which he will bring to the role of chair. Having worked with Ian since he joined the board in 2018, I am entirely confident that he is the right person to lead Archangels into the next exciting chapter of its growth.”

For further information on Archangels, please visit: https://archangelsonline.com/ 

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More